Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biosurfactants as Stabilizers of Silver Nanoparticles: A Sustainable Approach for Antimicrobial Applications.

Microorganisms·2026
Same author

Insights into a new class of antileishmanial compounds: an in vitro and in silico study of 1,2,4-oxadiazol-5(4H)-one derivatives.

Bioorganic chemistry·2026
Same author

Chemical Diversity of Three Endophytic Talaromyces Strains and Their Potential for Biocontrol against the Cocoa Pathogenic Fungus.

Chemistry & biodiversity·2026
Same author

Three new quinones from <i>Senna pluribracteata</i> (Fabaceae) and investigation of their bioactivity in BV-2 microglial cells.

Natural product research·2025
Same author

New Phenylpropanoid from <i>Croton velutinus</i> (Euphorbiaceae) as Potential Anticancer Natural Product Targeting MAPKs: Review with Docking Approach.

Current pharmaceutical design·2025
Same author

Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells.

Pharmaceutics·2025

Related Experiment Video

Updated: Jun 5, 2026

Applications of Liquid-Chromatography Tandem Mass Spectrometry in Natural Products Research: Tropane Alkaloids as a Case Study
09:36

Applications of Liquid-Chromatography Tandem Mass Spectrometry in Natural Products Research: Tropane Alkaloids as a Case Study

Published on: March 8, 2024

Tropane alkaloids from Erythroxylum caatingae Plowman.

Steno L de Oliveira1, Josean F Tavares, Marianna V S Castello Branco

  • 1Departamento de Ciências Farmacêuticas, Laboratório de Tecnologia Farmacêutica, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.

Chemistry & Biodiversity
|January 25, 2011
PubMed
Summary

Researchers isolated a new tropane alkaloid, 6β-benzoyloxy-3α-[(4-hydroxy-3,5-dimethoxybenzoyl)oxy]tropane, from Erythroxylum caatingae. Further analysis revealed five additional alkaloids, with two potentially new natural products, and preliminary cytotoxicity and antitumor activity were assessed.

More Related Videos

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
05:19

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

Applications of Liquid-Chromatography Tandem Mass Spectrometry in Natural Products Research: Tropane Alkaloids as a Case Study
09:36

Applications of Liquid-Chromatography Tandem Mass Spectrometry in Natural Products Research: Tropane Alkaloids as a Case Study

Published on: March 8, 2024

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
05:19

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Area of Science:

  • Phytochemistry
  • Natural Product Chemistry
  • Pharmacognosy

Background:

  • Erythroxylum caatingae is a plant species known to produce bioactive compounds.
  • Tropane alkaloids are a class of nitrogen-containing natural products with diverse pharmacological activities.
  • Understanding the chemical constituents of medicinal plants is crucial for drug discovery.

Purpose of the Study:

  • To isolate and characterize tropane alkaloids from Erythroxylum caatingae.
  • To identify novel natural products from this plant source.
  • To evaluate the preliminary cytotoxic and antitumor activities of isolated compounds and extracts.

Main Methods:

  • Isolation of alkaloids using chromatographic techniques.
  • Structure elucidation of isolated compounds using 2D NMR (1H and 13C) and LC/ESI-MS/MS.
  • X-ray crystallography was employed to confirm the structure of a new alkaloid derivative.
  • Cytotoxicity assays against HEp-2, NCI-H292, and KB cell lines.
  • Antitumor activity testing against Sarcoma 180.

Main Results:

  • Three tropane alkaloids were isolated and identified: 6β-benzoyloxy-3α-[(4-hydroxy-3,5-dimethoxybenzoyl)oxy]tropane (1, a new alkaloid), 3α,6β-dibenzoyloxytropane (2), and 6β-benzoyloxy-3α-[(3,4,5-trimethoxybenzoyl)oxy]tropane (3, catuabine B).
  • LC/ESI-MS/MS analysis indicated the presence of five additional alkaloids (4-8), with compounds 4 and 8 being potentially new.
  • X-ray crystallography confirmed the structure of compound 1.
  • The methanol extract and alkaloid 3 showed preliminary cytotoxic activity, and the methanol extract exhibited antitumor activity.

Conclusions:

  • Erythroxylum caatingae is a source of diverse tropane alkaloids, including a novel compound.
  • The identified alkaloids warrant further investigation for their pharmacological potential.
  • Preliminary biological activity suggests potential therapeutic applications for Erythroxylum caatingae constituents.